JOURNAL ARTICLE
Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy
Parakkal DeepakHumberto SifuentesRumi SemerEli D. Ehrenpreis
Year: 2011 Journal: European Journal of Gastroenterology & Hepatology Vol: 23 (12)Pages: 1150-1156 Publisher: Lippincott Williams & Wilkins
Abstract
HSTCL is no longer restricted to the previously identified risk group of young male patients, but can also occur in patients with rheumatoid arthritis, females and older adults receiving TNF-α inhibitors and immunomodulators. Improved disease outcomes using combination therapy should be tempered by the risk of developing HSTCL.
Keywords:
Medicine Infliximab Azathioprine Adalimumab Etanercept Internal medicine Rheumatoid arthritis Sulfasalazine Inflammatory bowel disease Gastroenterology Surgery Ulcerative colitis Disease
Metrics
107
Cited By
8.41
FWCI (Field Weighted Citation Impact)
24
Refs
0.98
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Citation History
Topics
Lymphoma Diagnosis and Treatment
Health Sciences → Medicine → Pathology and Forensic Medicine
Chronic Lymphocytic Leukemia Research
Health Sciences → Medicine → Genetics
Inflammatory Bowel Disease
Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics
Related Documents
JOURNAL ARTICLE
Biological therapy-related hepatosplenic T-cell lymphoma
Journal: Reactions Weekly Year: 2020 Vol: 1790 (1)Pages: 6-6
JOURNAL ARTICLE
Hepatosplenic T‐cell lymphoma
Journal: British Journal of Haematology Year: 2001 Vol: 114 (1)Pages: 3-3
BOOK-CHAPTER
Hepatosplenic T-cell Lymphoma
Faramarz NaeimP. Nagesh RaoSophie X. SongRyan T. Phan
Elsevier eBooks Year: 2008 Pages: 709-715
JOURNAL ARTICLE
Hepatosplenic T Cell Lymphoma
Nadeem Noor Mohammad khanFarah JijinaAmita JoshiPrajakta GupteRachana Chaturvedi
Journal: Indian Journal of Hematology and Blood Transfusion Year: 2013 Vol: 30 (S1)Pages: 21-23